Related references
Note: Only part of the references are listed.Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
Takashi Ishida et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeting SDF-1/CXCL12 with a Ligand That Prevents Activation of CXCR4 through Structure-Based Drug Design
Christopher T. Veldkamp et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
Sven Jahnichen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Single-domain antibodies as building blocks for novel therapeutics
Dirk Saerens et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Small neutralizing molecules to inhibit actions of the chemokine CXCL12
Muriel Hachet-Haas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Ticks produce highly selective chemokine binding proteins with antiinflammatory activity
Maud Deruaz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors
Dennis Verzijl et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy
G. H. Tesch
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Properties, production, and applications of camelid single-domain antibody fragments
M. M. Harmsen et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2007)
Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo
Robert D. Loberg et al.
CANCER RESEARCH (2007)
Molecular cloning and characterization of a highly selective chemokine-binding protein from the tick Rhipicephalus sanguineus
Achim Frauenschuh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration
Robert D. Loberg et al.
NEOPLASIA (2007)
Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies
Rob C. Roovers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases
Matt J. Craig et al.
CANCER AND METASTASIS REVIEWS (2006)
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Jennifer M. Burns et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Reliable and controllable antibody fragment selections from Camelid non-immune libraries for target validation
Peter Verheesen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2006)
The biological relevance of chemokine-proteoglycan interactions
A. E. I. Proudfoot
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments
J. M. van der Vaart et al.
VACCINE (2006)
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
E De Genst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
K Balabanian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen
E Dolk et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2005)
Multi-faceted strategies to combat disease by interference with the chemokine system
Z Johnson et al.
TRENDS IN IMMUNOLOGY (2005)
Post-translational control of chemokines: a role for,decoy receptors?
L Comerford et al.
IMMUNOLOGY LETTERS (2005)
Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo
E Dolk et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)
Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies - African trypanosomes as paradigm
B Stijlemans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
Chemokines in the pathogenesis of vascular disease
IF Charo et al.
CIRCULATION RESEARCH (2004)
The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)
DJ Mahad et al.
SEMINARS IN IMMUNOLOGY (2003)
Viral mimicry of cytokines, chemokines and their receptors
A Alcami
NATURE REVIEWS IMMUNOLOGY (2003)
Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68
KK Jensen et al.
JOURNAL OF VIROLOGY (2003)
Single-domain antibody fragments with high conformational stability
M Dumoulin et al.
PROTEIN SCIENCE (2002)
A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C axe weak partial agonists
WB Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Target validation of G-protein coupled receptors
A Wise et al.
DRUG DISCOVERY TODAY (2002)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Role of Rantes in experimental cardiac allograft rejection
MS Mulligan et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2000)
Requirement of the chemokine receptor CXCR3 for acute allograft rejection
WW Hancock et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Critical involvement of the chemotactic axis CXCR4/stromal cell-derived factor-1α in the inflammatory component of allergic airway disease
JA Gonzalo et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
